Cargando…
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
The claudin18.2 (CLDN18.2) protein, an isoform of claudin18, a member of the tight junction protein family, is a highly selective biomarker with limited expression in normal tissues and often abnormal expression during the occurrence and development of various primary malignant tumors, such as gastr...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153115/ https://www.ncbi.nlm.nih.gov/pubmed/35642043 http://dx.doi.org/10.1186/s40364-022-00385-1 |